Clinical Approach to Constipation
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of constipation
Constipation is one of the most common gastrointestinal complaints, affecting approximately 16% of adults worldwide and up to 33% of adults over age 60. In the United States alone, constipation accounts for more than 2.5 million physician visits annually and results in over 700,000 emergency department visits each year. The annual direct healthcare costs associated with constipation exceed $230 million, with additional substantial indirect costs from lost productivity and reduced quality of life.
Definition
Constipation is a symptom-based disorder characterized by difficult, infrequent, or incomplete defecation. According to the Rome IV criteria, chronic functional constipation requires the presence of at least two of the following symptoms for at least 3 months: straining during more than 25% of defecations, lumpy or hard stools in more than 25% of defecations, sensation of incomplete evacuation in more than 25% of defecations, sensation of anorectal obstruction in more than 25% of defecations, manual maneuvers to facilitate more than 25% of defecations, or fewer than three spontaneous bowel movements per week.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 1 week | Dietary changes, travel, new medications, acute illness, immobility | Usually self-limiting; requires urgent evaluation if accompanied by alarm features |
| Subacute | 1 week to 3 months | Medication side effects, lifestyle factors, early organic disease | Warrants investigation if not responding to initial management; consider secondary causes |
| Chronic | Greater than 3 months | Functional constipation, irritable bowel syndrome with constipation, slow-transit constipation, pelvic floor dysfunction, metabolic disorders | Requires systematic evaluation; often multifactorial; significant impact on quality of life |
Classification by Underlying Mechanism
Primary (Functional) Constipation
No identifiable organic, systemic, or pharmacological cause. Includes three subtypes: normal-transit constipation (most common, approximately 60%), slow-transit constipation (delayed colonic motility), and defecatory disorders (pelvic floor dysfunction, dyssynergic defecation). Diagnosis requires exclusion of secondary causes.
Secondary Constipation
Attributable to an identifiable cause including medications (opioids, anticholinergics), metabolic disorders (hypothyroidism, hypercalcemia, diabetes mellitus), neurological conditions (Parkinson disease, multiple sclerosis, spinal cord injury), structural abnormalities (colorectal cancer, strictures), or systemic diseases (scleroderma, amyloidosis).
Classification by Stool Characteristics
| Bristol Stool Type | Description | Clinical Interpretation |
|---|---|---|
| Type 1 | Separate hard lumps, like nuts (difficult to pass) | Severe constipation; prolonged colonic transit time (approximately 100 hours) |
| Type 2 | Sausage-shaped but lumpy | Mild constipation; indicates slow transit |
| Type 3 | Sausage-shaped with cracks on surface | Normal; optimal stool form |
| Type 4 | Smooth and soft, like a sausage or snake | Normal; ideal stool form |
Subtypes of Chronic Functional Constipation
| Subtype | Prevalence | Key Features | Pathophysiology |
|---|---|---|---|
| Normal-Transit Constipation | Approximately 60% | Perceived difficulty despite normal colonic transit; often associated with hard stools or bloating | Heightened visceral sensitivity; psychosocial factors |
| Slow-Transit Constipation | Approximately 15-20% | Infrequent bowel movements, reduced urge to defecate, bloating; often refractory to fiber | Colonic dysmotility; reduced high-amplitude propagating contractions |
| Defecatory Disorders | Approximately 25-30% | Straining, incomplete evacuation, need for digital maneuvers; sensation of blockage | Pelvic floor dyssynergia; inadequate rectal propulsion; structural abnormalities |
| Overlap/Mixed | Common | Features of multiple subtypes | Combination of mechanisms |
Key Concept — The Three Essential Questions: When approaching constipation, always determine: (1) Is this acute or chronic? (2) Is this primary (functional) or secondary? (3) If functional, which subtype — normal-transit, slow-transit, or defecatory disorder? This classification guides investigation and treatment. Remember that up to 50% of patients with chronic constipation may have overlapping subtypes.
Clinical Impact
Constipation significantly impairs quality of life, with studies showing comparable impact to chronic conditions such as diabetes, hypertension, and depression. Patients report decreased physical functioning, increased anxiety, and social limitations. Chronic constipation is also associated with increased healthcare utilization and work absenteeism. Recognition of this burden is essential for appropriate clinical attention and resource allocation.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of constipation
Normal defecation requires coordinated interaction between colonic motility, anorectal sensation, pelvic floor function, and conscious control. Understanding these mechanisms is essential for identifying the specific dysfunction in each patient and selecting appropriate therapy. Constipation can result from disruption at any point along this pathway.
Normal Colonic and Defecation Physiology
| Component | Structure | Function |
|---|---|---|
| Colonic Motility | Circular and longitudinal smooth muscle; interstitial cells of Cajal; enteric nervous system | Segmental contractions for mixing and absorption; high-amplitude propagating contractions (HAPCs) for mass movement (typically 6-8 per day, often postprandially) |
| Rectal Reservoir | Rectum with compliant wall; rectal sensory receptors | Stores stool; stretch receptors detect distension and trigger urge to defecate at approximately 150-200 mL volume |
| Internal Anal Sphincter | Smooth muscle; involuntary control; tonically contracted | Maintains continence at rest; relaxes via rectoanal inhibitory reflex when rectum distends |
| External Anal Sphincter | Striated muscle; voluntary control; pudendal nerve innervation | Maintains continence; consciously relaxed during defecation; can contract to defer defecation |
| Puborectalis Muscle | Striated muscle sling; part of levator ani complex | Maintains anorectal angle (approximately 90 degrees at rest); relaxation during defecation straightens angle to 130-140 degrees, facilitating evacuation |
The Defecation Sequence
Normal Defecation — Step by Step:
- Colonic propulsion: High-amplitude propagating contractions move stool into the rectum
- Rectal distension: Stretch receptors signal to the brain, creating the urge to defecate
- Rectoanal inhibitory reflex: Internal anal sphincter reflexively relaxes
- Conscious decision: If socially appropriate, voluntary initiation of defecation
- Positioning: Assuming squat or seated position increases anorectal angle
- Coordinated relaxation: External anal sphincter and puborectalis relax
- Increased intra-abdominal pressure: Valsalva maneuver provides propulsive force
- Evacuation: Coordinated rectal contraction expels stool
Pathophysiological Mechanisms by Subtype
Normal-Transit Constipation
Mechanism: Stool moves through the colon at a normal rate, but patients perceive constipation
Pathophysiology: Visceral hypersensitivity, altered perception, psychological factors, dietary factors affecting stool consistency
Clinical relevance: Responds well to fiber, osmotic laxatives, and lifestyle modification; reassurance is therapeutic
Slow-Transit Constipation
Mechanism: Delayed passage of stool through the colon due to reduced propulsive activity
Pathophysiology: Reduced interstitial cells of Cajal, decreased high-amplitude propagating contractions, possible enteric neuropathy
Clinical relevance: Poor response to fiber alone (may worsen bloating); requires prokinetics or stimulant laxatives; may need colectomy in severe refractory cases
Defecatory Disorders
Mechanism: Inability to coordinate the muscles involved in defecation despite adequate colonic transit
Pathophysiology: Dyssynergic defecation (paradoxical contraction of pelvic floor), inadequate rectal propulsion, structural abnormalities (rectocele, intussusception)
Clinical relevance: Biofeedback therapy is first-line and highly effective (70% success rate); laxatives alone often insufficient
How Secondary Conditions Cause Constipation
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Opioid-Induced Constipation | Mu-opioid receptor activation in the enteric nervous system reduces peristalsis, increases fluid absorption, and raises anal sphincter tone | Peripherally-acting mu-opioid receptor antagonists (methylnaltrexone, naloxegol) specifically target gut receptors without affecting analgesia |
| Hypothyroidism | Reduced metabolic rate slows colonic motility; decreased gastrointestinal smooth muscle contractility | Thyroid hormone replacement often resolves constipation; screen with thyroid-stimulating hormone in new-onset constipation |
| Diabetes Mellitus | Autonomic neuropathy affecting enteric nervous system; impaired colonic motility and rectal sensation | Optimize glycemic control; prokinetics may help; evaluate for coexisting defecatory disorders |
| Parkinson Disease | Alpha-synuclein deposition in enteric neurons; loss of dopaminergic input; colonic dysmotility often precedes motor symptoms by years | Multimodal approach needed; avoid anticholinergics which worsen both constipation and cognition |
| Hypercalcemia | Calcium reduces smooth muscle excitability and neuromuscular transmission; also causes dehydration via nephrogenic diabetes insipidus | Treat underlying cause; hydration; constipation resolves when calcium normalizes |
| Multiple Sclerosis | Demyelination of spinal cord pathways disrupts autonomic control of bowel; pelvic floor dyssynergia common | Combination therapy often needed; biofeedback for pelvic floor dysfunction; scheduled toileting programs |
| Colorectal Cancer | Mechanical obstruction from tumor mass; partial obstruction may present as progressive constipation before complete obstruction | Urgent evaluation required; new-onset constipation in patients over age 50 with alarm features warrants colonoscopy |
| Systemic Sclerosis (Scleroderma) | Smooth muscle atrophy and fibrosis; enteric neuropathy; reduced colonic motility | Prokinetics; avoid high-fiber diet which may cause obstruction; small frequent meals |
Mechanisms of Drug-Induced Constipation
| Drug Class | Mechanism | Examples |
|---|---|---|
| Opioids | Mu-receptor activation reduces peristalsis, increases fluid absorption, increases sphincter tone | Morphine, oxycodone, fentanyl, codeine, tramadol |
| Anticholinergics | Block muscarinic receptors on smooth muscle, reducing contractility and secretions | Antihistamines (diphenhydramine), tricyclic antidepressants, antipsychotics, antispasmodics (oxybutynin) |
| Calcium Channel Blockers | Inhibit smooth muscle contraction by blocking calcium entry; reduce colonic motility | Verapamil (highest risk), diltiazem, nifedipine |
| Iron Supplements | Direct irritant effect on mucosa; astringent properties; altered gut microbiome | Ferrous sulfate, ferrous gluconate |
| Diuretics | Dehydration and electrolyte imbalances (particularly hypokalemia) reduce colonic motility | Furosemide, hydrochlorothiazide |
| Aluminum-Containing Antacids | Aluminum ions bind phosphate and water in the gut; form insoluble complexite; slow transit | Aluminum hydroxide |
Often Overlooked Mechanism — The Defecation Deferral Cycle
Repeatedly ignoring the urge to defecate leads to a self-perpetuating cycle of constipation. When defecation is habitually deferred, the rectum becomes desensitized to distension, requiring progressively larger volumes to trigger the urge. Meanwhile, prolonged stool retention leads to increased water absorption, harder stools, and more difficult evacuation. This “learned” suppression of the defecation reflex is common in patients with busy lifestyles, those with limited bathroom access, or individuals who avoid public restrooms. Treatment requires scheduled toileting, often 15-30 minutes after meals to capitalize on the gastrocolic reflex, combined with patient education about the importance of responding to the urge promptly.
Complications and Consequences of Chronic Constipation
| Complication | Mechanism | Clinical Features |
|---|---|---|
| Fecal Impaction | Hard stool mass accumulates in rectum and cannot be evacuated; becomes increasingly dehydrated | Paradoxical diarrhea (overflow incontinence), abdominal pain, nausea, urinary retention; common in elderly and institutionalized patients |
| Hemorrhoids | Chronic straining increases intra-abdominal pressure, causing venous engorgement of hemorrhoidal cushions | Painless rectal bleeding, pruritus, prolapse; internal versus external |
| Anal Fissure | Passage of hard, large stools causes tearing of anal mucosa; internal sphincter spasm perpetuates ischemia and poor healing | Severe pain during and after defecation, bright red blood on toilet paper; usually posterior midline |
| Rectal Prolapse | Chronic straining and pelvic floor weakness leads to protrusion of rectal mucosa or full-thickness rectal wall | Sensation of tissue protruding, mucous discharge, fecal incontinence; associated with constipation and pelvic floor disorders |
| Stercoral Ulcer and Perforation | Pressure necrosis from impacted fecal mass against colonic wall; may lead to perforation | Rare but potentially fatal; presents with peritonitis; occurs in sigmoid or rectum; seen in elderly, immobile, or neurologically impaired patients |
3. History Taking
A comprehensive approach to eliciting the constipation history
Red Flags — Require Urgent Evaluation
- Rectal bleeding or melena — Suggests colorectal malignancy, inflammatory bowel disease, or ischemia
- Unintentional weight loss (greater than 5% in 6 months) — Malignancy until proven otherwise
- New-onset constipation after age 50 — Increased risk of colorectal cancer; warrants colonoscopy
- Iron deficiency anemia — Occult gastrointestinal blood loss; requires investigation
- Family history of colorectal cancer or inflammatory bowel disease — Heightened suspicion for organic pathology
- Progressive worsening despite treatment — Consider mechanical obstruction or malignancy
- Acute severe constipation with abdominal distension and vomiting — Possible bowel obstruction; surgical emergency
- Neurological symptoms — New weakness, sensory changes, or urinary retention suggest spinal cord pathology
Systematic History: The “STRAIN” Approach
Use the mnemonic “STRAIN” to ensure comprehensive history taking for constipation:
- S — Stool Form and Frequency: How often do you have a bowel movement? What do your stools look like (use Bristol Stool Chart)? Has this changed from your baseline?
- T — Timing, Triggers, and Duration: When did this start? Was the onset sudden or gradual? What makes it better or worse? Is there a pattern (worse when traveling, with certain foods)?
- R — Red Flags and Rectal Symptoms: Any blood in the stool? Weight loss? Do you feel the need to strain? Sensation of incomplete evacuation? Need to use fingers to help evacuate?
- A — Associated Symptoms and Abdomen: Abdominal pain or bloating? Nausea? Do you pass gas normally? Any alternation between constipation and diarrhea?
- I — Impact and Interventions: How does this affect your daily life? What have you tried (fiber, laxatives, dietary changes)? Did these help? How often do you use laxatives?
- N — New Medications and Lifestyle: Any new medications? Review all current medications including over-the-counter. Diet (fiber and fluid intake)? Exercise level? Bathroom habits? Do you ignore the urge to defecate?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Colorectal Cancer | New onset in older adult, progressive, alarm features | “Have you noticed any blood in your stool, unexplained weight loss, or a change in the caliber of your stool?” |
| Irritable Bowel Syndrome with Constipation | Chronic symptoms, abdominal pain related to defecation, bloating | “Does your abdominal pain improve after you have a bowel movement? Do your symptoms come and go in episodes?” |
| Defecatory Disorder (Dyssynergia) | Excessive straining, incomplete evacuation, need for manual maneuvers | “Do you ever need to press around your vagina or rectum, or use your fingers to help stool come out? Does it feel like something is blocking the stool?” |
| Slow-Transit Constipation | Infrequent urge, bloating, poor response to fiber | “Do you rarely feel the urge to have a bowel movement? Does eating more fiber make your bloating worse?” |
| Opioid-Induced Constipation | Constipation onset correlates with opioid use, hard stools, incomplete evacuation | “When did you start taking your pain medication? Did your constipation begin around the same time?” |
| Hypothyroidism | Fatigue, cold intolerance, weight gain, dry skin | “Have you noticed feeling more tired than usual, gaining weight, or being more sensitive to cold?” |
| Hypercalcemia | Polyuria, polydipsia, confusion, bone pain | “Have you been urinating more than usual or feeling unusually thirsty? Any confusion or bone pain?” |
| Parkinson Disease | Constipation often precedes motor symptoms, tremor, rigidity, bradykinesia | “Have you or your family noticed any tremor, changes in your handwriting, or that you’re moving more slowly?” |
| Depression | Low mood, anhedonia, psychomotor retardation, poor self-care | “How has your mood been? Have you lost interest in activities you used to enjoy?” |
| Eating Disorder | Weight concerns, restricted intake, laxative misuse, young patient | “Can you tell me about your eating habits? Have you ever used laxatives to control your weight?” |
Medication and Social History
Medications That Cause Constipation
- Opioids — Most common drug cause; affects nearly all chronic users
- Anticholinergics — Antihistamines, tricyclic antidepressants, antipsychotics, bladder antispasmodics
- Calcium channel blockers — Particularly verapamil and diltiazem
- Iron supplements — Especially ferrous sulfate
- Calcium and aluminum antacids — Calcium carbonate, aluminum hydroxide
- Diuretics — Via dehydration and hypokalemia
- Antiparkinson drugs — Dopamine agonists, anticholinergics
- Anticonvulsants — Carbamazepine, phenytoin
- Clonidine — Alpha-2 agonist reduces gut motility
- 5-HT3 antagonists — Ondansetron and related antiemetics
Social and Lifestyle History
- Diet: Fiber intake (goal 25-30 grams daily), fluid intake, meal patterns
- Physical activity: Sedentary lifestyle strongly associated with constipation
- Bathroom habits: Ignoring urge to defecate, inadequate time, lack of privacy
- Toilet posture: Western toilets versus squatting position
- Travel: Change in routine, dehydration, altered diet
- Occupation: Sedentary work, inability to access bathroom, shift work
- Psychosocial factors: Stress, anxiety, depression, history of abuse
- Laxative use history: Types, frequency, duration, escalating doses
- Pregnancy: Hormonal changes, iron supplements, mechanical factors
- Recent changes: Surgery, hospitalization, immobility
Rome IV Diagnostic Criteria for Functional Constipation
Diagnostic Criteria — Must Include Two or More
Symptoms present for at least 3 months with onset at least 6 months before diagnosis:
- Straining during more than 25% of defecations
- Lumpy or hard stools (Bristol Stool Form Scale 1-2) in more than 25% of defecations
- Sensation of incomplete evacuation in more than 25% of defecations
- Sensation of anorectal obstruction or blockage in more than 25% of defecations
- Manual maneuvers to facilitate more than 25% of defecations (digital evacuation, pelvic floor support)
- Fewer than 3 spontaneous bowel movements per week
Additional criteria: Loose stools rarely present without laxatives; insufficient criteria for irritable bowel syndrome.
Assessing Impact on Quality of Life
| Domain | Questions to Ask | Clinical Significance |
|---|---|---|
| Physical Functioning | “Does constipation limit your daily activities or work?” | Helps prioritize treatment intensity and monitor response |
| Psychological Impact | “Do you worry about your bowels? Does it affect your mood?” | Anxiety and depression common; may require concurrent treatment |
| Social Function | “Do you avoid social situations because of your bowel symptoms?” | Severe impact suggests need for aggressive management |
| Treatment Satisfaction | “How satisfied are you with your current bowel function?” | Patient goals may differ from objective measures; guides shared decision-making |
4. Physical Examination
A systematic approach for evaluating patients with constipation
Systematic Framework: Use the “General → Abdomen → Perineum → Digital Rectal Examination” approach for complete evaluation of patients presenting with constipation. The digital rectal examination is essential and should not be omitted.
General Inspection
- Overall appearance: Nutritional status (cachexia suggests malignancy or severe chronic disease), hydration status
- Signs of systemic disease: Pallor (anemia), jaundice (liver disease), myxedematous facies (hypothyroidism)
- Mobility: Assess mobility and functional status; immobility is a major risk factor
- Neurological: Observe gait, tremor, and bradykinesia (Parkinson disease); muscle weakness (neuromuscular disorder)
- Skin: Dry, coarse skin and hair loss (hypothyroidism); skin thickening (scleroderma)
- Mental status: Confusion may indicate hypercalcemia, hypothyroidism, or medication effects
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever or hypothermia | Fever may indicate infection (diverticulitis, stercoral colitis); hypothermia in severe hypothyroidism |
| Heart Rate | Bradycardia or tachycardia | Bradycardia in hypothyroidism; tachycardia in dehydration, infection, or obstruction |
| Blood Pressure | Hypotension, orthostatic changes | Dehydration, autonomic dysfunction (diabetes, Parkinson disease); orthostatic hypotension common in elderly with constipation |
| Respiratory Rate | Tachypnea | May indicate severe abdominal distension, metabolic acidosis, or anxiety |
| Weight | Unintentional weight loss or weight gain | Weight loss suggests malignancy; weight gain in hypothyroidism or edematous states |
Abdominal Examination
Inspection
- Distension: Generalized distension suggests fecal loading, obstruction, or ascites
- Visible peristalsis: Seen in thin patients with obstruction; “ladder pattern”
- Scars: Previous abdominal surgery (adhesions); midline scars increase obstruction risk
- Hernias: Inspect umbilicus, inguinal regions, and old incision sites
- Skin changes: Cullen sign or Grey Turner sign (rare; suggests complicated disease)
Auscultation
- Normal bowel sounds: Present but may be reduced in severe constipation
- High-pitched, tinkling sounds: Suggest mechanical obstruction
- Absent bowel sounds: Concerning for ileus or late obstruction; auscultate for at least 2 minutes before declaring absent
Percussion
- Tympany: Air-filled loops in obstruction or aerophagia
- Dullness: Stool-filled colon (often left lower quadrant), masses, or ascites
- Shifting dullness: Suggests ascites rather than fecal loading
Palpation
- Fecal masses: Palpable, often in left lower quadrant along course of sigmoid and descending colon; firm, indentable, non-tender
- Tenderness: Localized tenderness may indicate fecal impaction, diverticulitis, or colorectal malignancy
- Masses: Fixed, hard, irregular mass suggests malignancy; distinguish from stool (stool is indentable)
- Hepatomegaly: May suggest metastatic disease
- Abdominal wall hernias: Palpate for defects, especially with Valsalva
Perineal Inspection
- External hemorrhoids: Skin tags, thrombosed hemorrhoids visible externally
- Anal fissure: Usually posterior midline; may see sentinel pile
- Rectal prolapse: May require patient to strain to demonstrate; concentric mucosal folds
- Fistula openings: May indicate Crohn disease or previous abscess
- Skin excoriation: Suggests fecal incontinence or chronic diarrhea
- Perianal descent: Excessive descent (greater than 3 cm) during straining suggests pelvic floor weakness
- Anal wink reflex: Stroking perianal skin causes anal contraction; absence suggests neurological lesion (S2-S4)
Digital Rectal Examination
Essential Examination — Do Not Omit
The digital rectal examination is indispensable in evaluating constipation. It can identify fecal impaction, rectal masses, anal stricture, and pelvic floor dysfunction. Document the findings systematically.
| Component | Normal Finding | Abnormal Finding and Significance |
|---|---|---|
| Resting anal tone | Firm, symmetric sphincter tone | Reduced tone: neurological disease, sphincter injury, chronic straining; Increased tone: anal fissure, anxiety |
| Squeeze pressure | Perceptible increase with voluntary squeeze | Weak squeeze suggests external sphincter or pudendal nerve dysfunction |
| Puborectalis relaxation | Muscle relaxes and anorectal angle opens during simulated defecation (bearing down) | Paradoxical contraction (dyssynergia): muscle tightens instead of relaxing — key finding in defecatory disorders |
| Rectal contents | Empty rectum or small amount of soft stool | Large amount of hard stool suggests fecal impaction; empty rectum with reported constipation suggests slow-transit or outlet dysfunction |
| Rectal masses | Smooth rectal walls | Mass, nodularity, or irregularity requires urgent investigation for malignancy |
| Rectocele | No anterior bulge | Anterior vaginal wall bulges into rectum during straining; may trap stool |
| Tenderness | Non-tender | Tenderness suggests inflammation, abscess, fissure, or proctalgia |
| Blood on glove | No blood | Blood suggests hemorrhoids, fissure, proctitis, or malignancy; requires further investigation |
Bedside Assessment for Dyssynergic Defecation
The Simulated Defecation Test
During digital rectal examination, ask the patient to bear down as if having a bowel movement while you assess:
- Normal response: The puborectalis muscle relaxes (you feel the finger being pushed out), anal sphincter relaxes, and perineum descends
- Dyssynergic pattern: The puborectalis paradoxically contracts (you feel increased pressure around your finger), sphincter fails to relax appropriately
This simple bedside test has approximately 75% sensitivity for detecting dyssynergia compared to formal anorectal manometry. If positive, referral for biofeedback therapy is indicated.
Additional Relevant Examinations
Thyroid Examination
Palpate for goiter, nodules. Look for other signs of hypothyroidism: delayed relaxation of ankle reflexes, periorbital edema, dry skin, bradycardia.
Neurological Examination
Assess for signs of Parkinson disease (rigidity, bradykinesia, tremor), multiple sclerosis (sensory level, hyperreflexia), spinal cord lesion (saddle anesthesia, lower limb weakness), or peripheral neuropathy.
Expected Findings by Etiology
| Condition | General Examination | Abdominal Examination | Rectal Examination |
|---|---|---|---|
| Functional Constipation | Usually normal | Often normal; may have palpable stool in left lower quadrant | May be normal; variable stool in rectum |
| Defecatory Disorder | Normal | Usually normal | Paradoxical puborectalis contraction on bearing down; may have rectocele |
| Fecal Impaction | May appear uncomfortable; confusion in elderly | Palpable fecal mass, often left lower quadrant; may have distension | Hard stool mass in rectum; may be unable to insert finger |
| Colorectal Cancer | Pallor, cachexia, lymphadenopathy (late) | May have palpable mass, hepatomegaly | Low rectal mass may be palpable; blood on glove |
| Hypothyroidism | Myxedematous facies, dry skin, bradycardia, delayed reflexes | Often normal | Normal or hard stool |
| Parkinson Disease | Masked facies, resting tremor, bradykinesia, cogwheel rigidity | Usually normal; may have distension | May have impaired sphincter relaxation |
| Bowel Obstruction | Dehydration, distress | Distension, tympany, high-pitched bowel sounds, visible peristalsis | Empty rectum in complete obstruction; may feel mass |
| Systemic Sclerosis | Skin thickening, sclerodactyly, telangiectasias, calcinosis | May have distension | Reduced sphincter tone |
Important Teaching Point
Normal examination is common! Most patients with chronic functional constipation, including normal-transit constipation and irritable bowel syndrome with constipation, will have an entirely normal physical examination. The absence of abnormal findings does not exclude significant pathology but supports a diagnosis of functional disorder after appropriate workup. Conversely, any abnormal findings on examination warrant thorough investigation to exclude organic disease.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Constipation (Duration: Less than 1 week)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 80%) | Dietary and lifestyle changes | Recent travel, reduced fluid intake, dietary change, reduced activity | None typically; resolves with return to normal routine |
| COMMON | New medication effect | Onset correlates with starting opioid, anticholinergic, or other constipating drug | Severe if causing impaction |
| COMMON | Post-surgical or post-hospitalization | Recent surgery (especially abdominal or pelvic), immobility, opioid analgesia, anesthesia effects | Abdominal distension, vomiting suggest ileus |
| LESS COMMON (approximately 15%) | Fecal impaction | Elderly, immobile, or neurologically impaired patients; paradoxical diarrhea (overflow) | Confusion, urinary retention, abdominal pain |
| LESS COMMON | Acute febrile illness | Dehydration, reduced oral intake, bed rest during illness | Signs of severe dehydration or systemic infection |
| UNCOMMON BUT SERIOUS (approximately 5%) | Bowel obstruction | Colicky abdominal pain, distension, vomiting, absolute constipation (no flatus) | Surgical emergency; peritonitis signs |
| UNCOMMON BUT SERIOUS | Acute spinal cord compression | Back pain, leg weakness, sensory level, urinary retention | Neurological emergency requiring urgent MRI |
| UNCOMMON BUT SERIOUS | Acute hypercalcemia | Confusion, polyuria, polydipsia, bone pain, nausea | Altered mental status; may indicate malignancy |
Chronic Constipation (Duration: Greater than 3 months)
Step-by-Step Approach to Chronic Constipation:
- Step 1: Rule out obvious secondary causes — Is the patient taking constipating medications? Are there alarm features requiring urgent investigation?
- Step 2: Exclude metabolic and systemic diseases — Check thyroid function, calcium, glucose; consider age-appropriate cancer screening
- Step 3: Apply Rome IV criteria — Does the patient meet criteria for functional constipation or irritable bowel syndrome with constipation?
- Step 4: Classify the functional subtype — Normal-transit, slow-transit, or defecatory disorder? This guides specific treatment
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Functional constipation — normal-transit type | 35-50% of chronic constipation | Hard stools, bloating, but normal colonic transit on testing; responds to fiber and osmotic laxatives |
| COMMON | Irritable bowel syndrome with constipation | 25-30% | Abdominal pain related to defecation; pain improves with bowel movement; bloating prominent; may alternate with diarrhea |
| COMMON | Medication-induced constipation | 20-30% | Clear temporal relationship to drug initiation; opioids, anticholinergics, calcium channel blockers most common |
| LESS COMMON | Defecatory disorders (dyssynergic defecation) | 15-25% | Excessive straining, incomplete evacuation, need for digital maneuvers; often younger women; responds to biofeedback |
| LESS COMMON | Slow-transit constipation | 10-15% | Infrequent urge to defecate, bloating worsened by fiber; predominantly women; poor response to conventional treatment |
| LESS COMMON | Hypothyroidism | 5-10% | Fatigue, cold intolerance, weight gain, dry skin; elevated thyroid-stimulating hormone |
| LESS COMMON | Diabetes mellitus with autonomic neuropathy | 5-10% | Long-standing diabetes, other autonomic features (gastroparesis, orthostatic hypotension, erectile dysfunction) |
| UNCOMMON BUT IMPORTANT | Colorectal cancer | 2-5% (higher with alarm features) | New onset after age 50, progressive symptoms, rectal bleeding, weight loss, iron deficiency anemia, family history |
| UNCOMMON | Parkinson disease | 1-3% | Constipation may precede motor symptoms; tremor, rigidity, bradykinesia; responds poorly to laxatives alone |
| UNCOMMON | Multiple sclerosis | Less than 1% | Young adults; other neurological symptoms; relapses and remissions |
| UNCOMMON | Systemic sclerosis | Less than 1% | Skin thickening, Raynaud phenomenon, dysphagia; gastrointestinal involvement common |
| UNCOMMON | Hypercalcemia (primary hyperparathyroidism, malignancy) | Less than 1% | “Stones, bones, groans, and moans”; polyuria, bone pain, confusion |
Anatomical Approach to Constipation
Colonic Causes
Colorectal cancer
Diverticular stricture
Inflammatory bowel disease stricture
Colonic dysmotility (slow-transit)
Megacolon (Hirschsprung disease, Chagas)
Post-radiation stricture
Anorectal Causes
Dyssynergic defecation
Rectocele
Rectal prolapse or intussusception
Anal stricture or stenosis
Anal fissure (with fear of defecation)
Rectal cancer
Neurological Causes
Parkinson disease
Multiple sclerosis
Spinal cord injury or lesion
Cauda equina syndrome
Autonomic neuropathy
Cerebrovascular disease
Metabolic and Systemic Causes
Hypothyroidism
Hypercalcemia
Diabetes mellitus
Hypokalemia
Systemic sclerosis
Amyloidosis
Drug-Induced Constipation — Comprehensive List
| Drug or Drug Class | Mechanism | Characteristics | Management Considerations |
|---|---|---|---|
| Opioids | Mu-receptor activation reduces peristalsis, increases fluid absorption | Affects nearly all chronic users; dose-dependent; tolerance does NOT develop | Prophylactic laxatives essential; peripherally-acting mu-opioid antagonists (methylnaltrexone, naloxegol) for refractory cases |
| Anticholinergics | Block muscarinic receptors; reduce smooth muscle contractility | Cumulative anticholinergic burden matters; elderly more susceptible | Calculate anticholinergic burden score; substitute with less anticholinergic alternatives |
| Tricyclic antidepressants | Anticholinergic effects predominant | Amitriptyline > nortriptyline in constipating effect | Consider switching to SSRI if constipation severe |
| Calcium channel blockers | Inhibit calcium-dependent smooth muscle contraction | Verapamil highest risk (up to 25%); diltiazem moderate; dihydropyridines lower risk | Switch to dihydropyridine or alternative antihypertensive class |
| Iron supplements | Direct mucosal irritation; astringent effect; alters microbiome | Ferrous sulfate worse than ferrous gluconate or fumarate | Consider alternate-day dosing, different salt, or parenteral iron |
| Aluminum-containing antacids | Aluminum binite forms insoluble complexes | Chronic use problematic; aluminum toxicity risk in renal impairment | Switch to magnesium-containing or proton pump inhibitor |
| Calcium supplements and calcium-containing antacids | Calcium reduces smooth muscle excitability | Dose-dependent; more common with calcium carbonate | Consider calcium citrate; ensure adequate hydration |
| Diuretics | Dehydration and hypokalemia impair colonic motility | Loop and thiazide diuretics; hypokalemia compounds effect | Ensure adequate hydration; correct electrolyte abnormalities |
| Antihistamines (first-generation) | Anticholinergic effects | Diphenhydramine, chlorpheniramine worse than second-generation | Use non-sedating antihistamines (cetirizine, loratadine) |
| Antipsychotics | Anticholinergic effects; also dopamine blockade may slow transit | Clozapine highest risk (may cause ileus); olanzapine moderate | Regular bowel monitoring essential; prophylactic laxatives with clozapine |
| Anticonvulsants | Sodium channel effects; anticholinergic properties | Carbamazepine, phenytoin, gabapentinoids | Monitor bowel function; standard laxative therapy |
| 5-HT3 antagonists | Block serotonin receptors in gut; slow transit | Ondansetron very constipating; used short-term usually | Limit duration; alternative antiemetics for chronic use |
| Clonidine | Alpha-2 agonism reduces gut secretion and motility | Dose-dependent effect | Standard laxative therapy; consider alternative antihypertensive |
| NSAIDs | Prostaglandin inhibition affects motility; not typically significant | Usually minor contributor; more impact on upper GI | Rarely need to stop for constipation alone |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| New constipation in patient over 50 with weight loss or rectal bleeding | Colorectal cancer | Urgent colonoscopy |
| Constipation onset correlates with starting opioids | Opioid-induced constipation | Start prophylactic laxatives; consider peripherally-acting mu-opioid antagonist |
| Excessive straining with need for digital maneuvers to evacuate | Defecatory disorder (dyssynergia) | Digital rectal examination for dyssynergia; referral for anorectal manometry and biofeedback |
| Bloating worsened by fiber, infrequent urge to defecate | Slow-transit constipation | Colonic transit study; stimulant laxatives or prokinetics |
| Abdominal pain improving with defecation, alternating bowel habits | Irritable bowel syndrome with constipation | Rome IV criteria; trial of low-FODMAP diet; antispasmodics |
| Fatigue, cold intolerance, dry skin, weight gain | Hypothyroidism | Check thyroid-stimulating hormone |
| Elderly patient with confusion and paradoxical diarrhea | Fecal impaction with overflow | Digital rectal examination; disimpaction |
| Tremor, bradykinesia, rigidity with longstanding constipation | Parkinson disease | Neurology referral; multimodal bowel program |
| Acute constipation with distension, vomiting, no flatus | Bowel obstruction | Urgent surgical evaluation; abdominal X-ray and CT |
| Constipation with polyuria, confusion, bone pain | Hypercalcemia | Check serum calcium; investigate underlying cause |
| Young woman with skin thickening, Raynaud phenomenon | Systemic sclerosis | Rheumatology referral; anti-nuclear antibody, anti-centromere, anti-Scl-70 |
| Constipation since childhood, massively dilated colon | Hirschsprung disease (adult presentation rare) | Rectal biopsy for ganglion cells; surgical referral |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Key Principle: Most patients with chronic constipation without alarm features do not require extensive investigation. A thorough history and physical examination, including digital rectal examination, can often establish the diagnosis. Reserve specialized testing for patients with alarm features, refractory symptoms, or when specific subtype classification will change management.
Baseline Investigations for All Patients with Chronic Constipation
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia suggesting occult blood loss | Microcytic anemia (iron deficiency); leukocytosis if infection | Iron deficiency anemia in adult mandates gastrointestinal investigation |
| Basic metabolic panel | Identify electrolyte abnormalities affecting motility | Hypokalemia, hypercalcemia, hyperglycemia | Hypokalemia may be cause or effect of laxative use |
| Thyroid-stimulating hormone | Exclude hypothyroidism | Elevated TSH indicates hypothyroidism | Should be checked in all patients with new chronic constipation; treatment may resolve symptoms |
| Serum calcium | Exclude hypercalcemia | Elevated total or ionized calcium | If elevated, investigate for primary hyperparathyroidism or malignancy |
| Fasting glucose or HbA1c | Screen for diabetes mellitus | Elevated glucose suggesting diabetes | Autonomic neuropathy develops in longstanding poorly controlled diabetes |
Indications for Colonoscopy
Colonoscopy is Indicated When
- Alarm features present: Rectal bleeding, iron deficiency anemia, unintentional weight loss greater than 5%, palpable abdominal or rectal mass
- Age-appropriate cancer screening due: New-onset constipation in patient over 45-50 years who has not had recent colonoscopy
- Family history: First-degree relative with colorectal cancer or adenomatous polyps before age 60
- Change in bowel habits: Recent change in pattern that is persistent and unexplained
- Positive fecal occult blood test or fecal immunochemical test
Note: Colonoscopy is NOT routinely indicated for chronic constipation without alarm features in patients up to date on colorectal cancer screening.
Targeted Investigations by Suspected Etiology
If Suspecting Defecatory Disorder (Dyssynergic Defecation)
First-Line Tests
- Digital rectal examination: Assess for paradoxical puborectalis contraction during simulated defecation (approximately 75% sensitivity)
- Balloon expulsion test: Patient attempts to expel a 50 mL water-filled balloon while seated; inability to expel within 1-2 minutes suggests defecatory disorder (sensitivity 80-90%)
Second-Line Tests (Specialist)
- Anorectal manometry: Gold standard; measures sphincter pressures, rectal sensation, rectoanal coordination; identifies dyssynergia pattern
- Defecography (barium or MRI): Visualizes pelvic floor anatomy and function during defecation; identifies rectocele, intussusception, excessive perineal descent
If Suspecting Slow-Transit Constipation
First-Line Tests
- Clinical assessment: Infrequent urge to defecate, bloating worsened by fiber, poor response to standard laxatives strongly suggests slow transit
- Abdominal X-ray: May show fecal loading throughout colon; non-specific but supportive
Second-Line Tests (Specialist)
- Radiopaque marker study (Sitz marks): Patient swallows capsule containing 24 radiopaque markers; abdominal X-ray at day 5; retention of greater than 20% of markers (more than 5) indicates slow transit; normal transit time less than 72 hours
- Wireless motility capsule (SmartPill): Measures regional and whole gut transit times, pressure, and pH; identifies colonic inertia
- Colonic scintigraphy: Nuclear medicine study tracking radiolabeled meal through colon; less widely available
If Suspecting Irritable Bowel Syndrome with Constipation
Diagnosis is Clinical
- Rome IV criteria: Recurrent abdominal pain at least 1 day per week for 3 months, associated with defecation, change in stool frequency, or change in stool form
- Limited testing approach: Complete blood count, C-reactive protein or erythrocyte sedimentation rate, celiac serology if diarrhea component
Tests to Exclude Other Diagnoses
- Celiac serology: Tissue transglutaminase IgA if any diarrhea component; 4x more common in IBS patients
- Stool calprotectin or lactoferrin: Elevated levels suggest inflammatory bowel disease rather than IBS
- Colonoscopy: Only if alarm features or age-appropriate screening due
If Suspecting Structural or Obstructive Cause
First-Line Tests
- Colonoscopy: Visualizes mucosal lesions, strictures, masses; allows biopsy; essential for alarm features
- CT colonography (virtual colonoscopy): Alternative if colonoscopy contraindicated or incomplete; detects masses and strictures
Additional Imaging
- CT abdomen and pelvis: Evaluates for mass, obstruction, or extra-luminal pathology; useful in acute presentations
- Abdominal X-ray: First-line for suspected obstruction; shows air-fluid levels, dilated loops; useful for assessing fecal loading
Specialist Physiological Testing — When and What
| Test | What It Measures | When to Order | Key Findings |
|---|---|---|---|
| Anorectal manometry | Anal sphincter pressures, rectal sensation, rectoanal coordination | Suspected defecatory disorder; refractory constipation before surgery; fecal incontinence | Dyssynergia: paradoxical increase in anal pressure or less than 20% relaxation during push; reduced rectal sensation |
| Balloon expulsion test | Ability to evacuate simulated stool | Screening for defecatory disorder; simple office-based test | Failure to expel 50 mL balloon within 1-2 minutes suggests outlet dysfunction |
| Defecography (barium or MRI) | Pelvic floor anatomy and dynamics during defecation | Suspected structural abnormality (rectocele, intussusception); preoperative planning | Rectocele greater than 2 cm with retention; rectal intussusception; excessive perineal descent greater than 3 cm |
| Colonic transit study (radiopaque markers) | Rate of colonic transit | Suspected slow-transit constipation; refractory to treatment; before considering surgery | Retention of greater than 20% of markers at day 5; diffuse retention suggests colonic inertia; segmental retention suggests outlet obstruction |
| Wireless motility capsule | Whole gut and regional transit times, pressure, pH | Alternative to radiopaque markers; also assesses gastric and small bowel transit | Colonic transit time greater than 59 hours abnormal; also identifies gastroparesis |
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach
In patients without alarm features, empiric treatment trials can serve as both therapy and diagnostic tool. Response to specific treatments supports certain diagnoses.
- Trial 1 — Fiber and osmotic laxatives for 4-8 weeks: Response supports normal-transit constipation or simple dietary insufficiency
- Trial 2 — Stimulant laxatives for 4 weeks: Good response despite failure of fiber suggests slow-transit component
- Trial 3 — Biofeedback therapy for 6-8 sessions: Response confirms defecatory disorder and provides treatment simultaneously
- Trial 4 — Low-FODMAP diet for 4-6 weeks: Response in patients with bloating and pain supports irritable bowel syndrome
Note: If empiric therapy fails, proceed to physiological testing to characterize the constipation subtype before escalating treatment.
Investigation Algorithm Summary
| Clinical Scenario | Recommended Investigations | Rationale |
|---|---|---|
| Chronic constipation, no alarm features, age less than 50 | Baseline bloods (CBC, TSH, calcium, glucose); digital rectal examination; empiric trial of fiber and laxatives | Low pretest probability of organic disease; treat empirically first |
| Chronic constipation, no alarm features, age 50 or older | Baseline bloods; colonoscopy if not up to date on screening; empiric treatment trial | Age-appropriate colorectal cancer screening indicated |
| Constipation with alarm features (any age) | Urgent colonoscopy; baseline bloods including iron studies; CT if obstruction suspected | Must exclude colorectal malignancy and other organic pathology |
| Constipation refractory to empiric therapy | Anorectal manometry; balloon expulsion test; colonic transit study | Subtype classification guides specific treatment (biofeedback vs prokinetics) |
| Suspected defecatory disorder | Digital rectal examination; balloon expulsion test; anorectal manometry; defecography if structural cause suspected | Confirm diagnosis before biofeedback; identify structural abnormalities requiring surgery |
| Constipation in Parkinson disease or neurological disorder | Baseline bloods; consider anorectal manometry; assess for combination of slow transit and outlet dysfunction | Often multifactorial; may need combination therapy |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Absolute constipation (no stool or flatus) with abdominal distension, vomiting, colicky pain | EMERGENT | Surgical consultation; NPO; IV fluids; nasogastric decompression; urgent CT abdomen |
| New constipation with back pain, leg weakness, urinary retention, saddle anesthesia | EMERGENT | Urgent MRI spine; neurosurgical consultation; suspected cauda equina syndrome |
| Severe constipation with confusion, dehydration in elderly patient | EMERGENT | Digital rectal examination for impaction; check calcium, renal function; IV hydration; disimpaction if needed |
| Constipation with rectal bleeding, weight loss, or iron deficiency anemia | URGENT | Urgent colonoscopy within 2 weeks; complete blood count, iron studies; do not delay for bowel preparation concerns |
| New-onset constipation in patient over 50 years without prior colonoscopy | URGENT | Colonoscopy within 4-6 weeks; baseline bloods; can start empiric treatment while awaiting |
| Acute constipation after starting new medication | URGENT | Review medication; consider discontinuation or substitution; initiate laxative therapy |
| Chronic constipation without alarm features, responding partially to treatment | ROUTINE | Optimize current therapy; consider physiological testing if refractory; schedule follow-up in 4-8 weeks |
| Mild chronic constipation, lifestyle factors identified | ROUTINE | Lifestyle modification counseling; fiber supplementation; follow-up in 4-6 weeks |
Step 2: Classify by Duration and Presentation
Acute (Less than 1 week)
Key Questions: New medications? Recent surgery or hospitalization? Dietary changes? Travel?
Action: Identify and address precipitant; rule out obstruction if severe; short-term laxative therapy
Subacute (1 week to 3 months)
Key Questions: Progressive or stable? Alarm features? Medication review complete?
Action: Baseline bloods; consider colonoscopy if alarm features or age over 50; empiric therapy trial
Chronic (Greater than 3 months)
Key Questions: Does patient meet Rome IV criteria? What treatments have been tried? Any response?
Action: Subtype classification; physiological testing if refractory; targeted therapy based on mechanism
Step 3: Follow the Appropriate Algorithm
Algorithm A: Initial Management of Chronic Constipation
| Step | Action | If Successful | If Unsuccessful |
|---|---|---|---|
| 1. Exclude secondary causes | Review medications; check TSH, calcium, glucose; colonoscopy if indicated | Treat underlying cause | Proceed to Step 2 |
| 2. Lifestyle modification | Increase fiber to 25-30 g/day; fluid intake 1.5-2 L/day; regular physical activity; scheduled toileting after meals | Continue; this is maintenance therapy | Proceed to Step 3 after 4 weeks |
| 3. Add osmotic laxative | Polyethylene glycol 17 g daily (first-line) or lactulose 15-30 mL twice daily | Continue; titrate to effect | Proceed to Step 4 after 4-8 weeks |
| 4. Add or switch to stimulant laxative | Bisacodyl 5-10 mg or senna 8.6-17.2 mg at bedtime; can combine with osmotic | Continue; use lowest effective dose | Proceed to Step 5 |
| 5. Evaluate for defecatory disorder | Digital rectal examination for dyssynergia; balloon expulsion test; anorectal manometry | If positive: biofeedback therapy | Proceed to Step 6 |
| 6. Assess colonic transit | Radiopaque marker study or wireless motility capsule | If slow transit confirmed: prokinetics, secretagogues | Specialist referral; consider combination therapy |
Algorithm B: Management Based on Constipation Subtype
| Subtype | First-Line Treatment | Second-Line Treatment | Refractory Options |
|---|---|---|---|
| Normal-Transit Constipation | Fiber supplementation; polyethylene glycol; lifestyle modification | Stimulant laxatives; lubiprostone or linaclotide | Combination therapy; prucalopride |
| Slow-Transit Constipation | Polyethylene glycol; stimulant laxatives (avoid excessive fiber which may worsen bloating) | Prucalopride (5-HT4 agonist); linaclotide or plecanatide (secretagogues) | Combination prokinetic and secretagogue; surgical evaluation (subtotal colectomy) for severe refractory cases |
| Defecatory Disorder | Biofeedback therapy (70% success rate); concurrent laxatives as needed | Botulinum toxin injection to puborectalis (if biofeedback fails) | Surgical repair if structural cause (rectocele, rectal prolapse); sacral nerve stimulation |
| Irritable Bowel Syndrome with Constipation | Soluble fiber; polyethylene glycol; low-FODMAP diet trial | Linaclotide or plecanatide (FDA-approved for IBS-C); lubiprostone | Tegaserod (restricted availability); tricyclic antidepressants (low dose); psychological therapies |
| Opioid-Induced Constipation | Prophylactic stimulant laxative plus osmotic laxative when starting opioid | Peripherally-acting mu-opioid receptor antagonists: methylnaltrexone, naloxegol, naldemedine | Opioid rotation; lubiprostone (FDA-approved for OIC); consider non-opioid analgesia |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient reports no bowel movement for 7+ days with discomfort | Digital rectal examination; abdominal X-ray if distended; consider disimpaction if impacted | Aggressive laxative regimen (polyethylene glycol bowel prep if severe); address underlying cause |
| Patient on opioids develops severe constipation | Escalate laxative therapy; add stimulant if only on osmotic | Start peripherally-acting mu-opioid receptor antagonist; never use regular naloxone (reverses analgesia) |
| Elderly patient with overflow diarrhea and confusion | Digital rectal examination confirms impaction; manual disimpaction; enemas | High-dose polyethylene glycol until clear; establish maintenance regimen; address mobility and hydration |
| Patient reports needing to digitate to evacuate | Assess for dyssynergia on digital rectal examination; check for rectocele | Referral for anorectal manometry and defecography; biofeedback therapy if dyssynergia confirmed |
| Fiber makes bloating worse | Suspect slow-transit constipation or IBS; reduce or stop fiber temporarily | Switch to osmotic and stimulant laxatives; consider transit study; trial low-FODMAP diet |
| Patient requests chronic stimulant laxative use | Reassure that long-term stimulant use is safe and does not cause dependence or “lazy bowel” | Optimize dose; consider adding osmotic laxative; address underlying cause if possible |
| Constipation persists despite multiple laxatives | Verify compliance and adequate dosing; digital rectal examination for impaction or dyssynergia | Physiological testing (anorectal manometry, transit study); consider specialist referral |
| Young patient with lifelong constipation and megacolon on imaging | Consider Hirschsprung disease (rare in adults); rectal biopsy for ganglion cells | Surgical referral if aganglionosis confirmed; may need subtotal colectomy |
| Patient with Parkinson disease and severe constipation | Review medications (avoid anticholinergics); assess for both slow transit and dyssynergia | Multimodal approach: polyethylene glycol, stimulants, prokinetics; biofeedback if dyssynergia present |
| Constipation in pregnancy | First-line: fiber, fluids, exercise; osmotic laxatives (polyethylene glycol, lactulose) safe in pregnancy | Stimulant laxatives (senna, bisacodyl) can be used short-term if needed; avoid mineral oil and castor oil |
Troubleshooting Refractory Constipation
Systematic Checklist for Treatment Failure
- Is the diagnosis correct? Reconsider secondary causes; repeat basic workup if not recently done
- Is there a defecatory disorder? Up to 50% of refractory constipation involves pelvic floor dysfunction — test before escalating laxatives
- Is there adequate treatment compliance? Ask specifically about actual medication use; cost and side effects are common barriers
- Are doses optimized? Many patients under-dose laxatives; polyethylene glycol can be increased to 34 g twice daily if needed
- Are there ongoing contributing factors? New medications, worsening comorbidities, dietary changes, reduced mobility
- Is there overlap of subtypes? Many patients have combined slow-transit and defecatory disorder — treat both
- Are patient expectations realistic? Discuss that goal is comfortable bowel movements, not necessarily daily movements
- Has specialist referral been considered? Gastroenterology referral for physiological testing and advanced therapies
When to Refer to a Specialist
| Indication | Referral Type | Expected Evaluation |
|---|---|---|
| Alarm features (bleeding, weight loss, anemia) | Gastroenterology — urgent | Colonoscopy; exclude malignancy |
| Refractory to standard laxative therapy (greater than 8-12 weeks) | Gastroenterology — motility specialist if available | Anorectal manometry; colonic transit study; biofeedback |
| Suspected defecatory disorder requiring biofeedback | Gastroenterology or pelvic floor physiotherapist | Confirmation testing; biofeedback therapy program |
| Structural anorectal abnormality (large rectocele, prolapse) | Colorectal surgery | Defecography; surgical repair evaluation |
| Severe slow-transit constipation refractory to all medical therapy | Colorectal surgery | Evaluation for subtotal colectomy with ileorectal anastomosis |
| Associated neurological symptoms or suspected neurological cause | Neurology | Evaluation for Parkinson disease, multiple sclerosis, spinal cord pathology |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The digital rectal examination is essential: It can identify fecal impaction, assess sphincter tone, detect masses, and screen for dyssynergia. A constipation workup without a digital rectal examination is incomplete.
Defecatory disorders are underdiagnosed: Up to 50% of patients with refractory chronic constipation have pelvic floor dysfunction. Ask about straining, incomplete evacuation, and need for digital maneuvers. Test before escalating laxatives.
Stimulant laxatives are safe for long-term use: The myth of “lazy bowel” or stimulant dependence is not supported by evidence. Chronic use of senna or bisacodyl is appropriate for patients who need it.
Opioid-induced constipation requires prophylaxis: Start a stimulant laxative when initiating opioid therapy. Tolerance to constipation does NOT develop, unlike other opioid side effects.
Fiber can make things worse in slow-transit constipation: Patients with colonic inertia often experience worsened bloating and discomfort with fiber supplementation. If fiber fails or worsens symptoms, try osmotic and stimulant laxatives instead.
Biofeedback is highly effective for dyssynergia: Success rates of 70-80% make biofeedback the first-line treatment for defecatory disorders. It is more effective than laxatives for this subtype.
Overflow incontinence mimics diarrhea: In elderly or immobile patients presenting with “diarrhea,” always consider fecal impaction with overflow. A digital rectal examination quickly clarifies the diagnosis.
Polyethylene glycol is first-line for a reason: It is safe, effective, well-tolerated, does not cause electrolyte disturbances, and can be titrated over a wide dose range. It is safe in pregnancy, elderly, and long-term use.
Critical Pitfalls to Avoid
Missing alarm features: New-onset constipation in patients over 50, rectal bleeding, weight loss, and iron deficiency anemia require colonoscopy. Do not attribute these to functional constipation without investigation.
Forgetting to check medications: Drug-induced constipation is extremely common and often overlooked. Always review the medication list — opioids, anticholinergics, calcium channel blockers, and iron are frequent culprits.
Skipping the digital rectal examination: It is uncomfortable for both patient and physician, but it provides critical information that cannot be obtained any other way. Make it routine in constipation evaluation.
Escalating laxatives without testing for dyssynergia: Patients with pelvic floor dysfunction will not respond to laxatives alone. Test for dyssynergia before concluding that constipation is refractory.
Using regular naloxone for opioid-induced constipation: Systemic naloxone will reverse analgesia and may precipitate withdrawal. Use peripherally-acting mu-opioid receptor antagonists (methylnaltrexone, naloxegol) which do not cross the blood-brain barrier.
Overlooking hypothyroidism: A simple thyroid-stimulating hormone test can identify a readily treatable cause of constipation. It should be checked in all patients with new chronic constipation.
Dismissing patient concerns about quality of life: Chronic constipation significantly impacts daily functioning and wellbeing. Take complaints seriously and treat aggressively enough to achieve patient satisfaction.
Failing to establish a maintenance regimen: Many patients require ongoing laxative therapy. Stopping treatment after improvement often leads to recurrence. Develop a sustainable long-term plan.
Key Takeaways
- Constipation affects 16% of adults and up to 33% of those over 60 years; it significantly impacts quality of life and healthcare costs
- Classify by duration (acute, subacute, chronic) and mechanism (primary versus secondary) to guide investigation and treatment
- Chronic functional constipation has three subtypes: normal-transit (60%), slow-transit (15-20%), and defecatory disorders (25-30%); many patients have overlap
- Red flags requiring urgent investigation include rectal bleeding, weight loss, anemia, new onset after age 50, and progressive symptoms despite treatment
- The digital rectal examination is essential — it assesses impaction, sphincter function, and can screen for dyssynergia during simulated defecation
- Most patients without alarm features can be managed empirically with lifestyle modification, fiber, and osmotic laxatives without extensive testing
- Defecatory disorders respond to biofeedback therapy (70-80% success rate), not escalating laxatives — test before concluding treatment failure
- Opioid-induced constipation requires prophylactic laxatives from day one; peripherally-acting mu-opioid receptor antagonists are effective for refractory cases
- Stimulant laxatives are safe for chronic use — the concept of “lazy bowel” is a myth not supported by evidence
- Specialist referral is indicated for alarm features, refractory symptoms despite adequate empiric therapy, or when physiological testing will change management
Quick Reference Algorithm
Systematic Approach to Constipation:
- Assess urgency: Identify emergent presentations (obstruction, cauda equina) and alarm features requiring urgent colonoscopy
- Take a focused history: Use the STRAIN mnemonic — Stool form, Timing, Red flags, Associated symptoms, Impact, New medications
- Perform digital rectal examination: Assess for impaction, masses, sphincter tone, and dyssynergia on simulated defecation
- Order baseline investigations: Complete blood count, thyroid-stimulating hormone, calcium, glucose; colonoscopy if alarm features or age-appropriate screening due
- Initiate empiric therapy: Lifestyle modification, fiber (unless bloating worsens), polyethylene glycol; add stimulant laxative if needed
- Reassess and classify: If refractory after 8-12 weeks, test for defecatory disorder (anorectal manometry, balloon expulsion) and slow transit (marker study)
- Target treatment to subtype: Biofeedback for dyssynergia; prokinetics or secretagogues for slow transit; low-FODMAP diet for irritable bowel syndrome with constipation
- Establish maintenance plan: Most patients require ongoing therapy; set realistic expectations; follow up to optimize outcomes